CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1

Cancer Research

Volumn 68, Issue 1, 2008, Pages 301-306

  Frietze, Seth ^a   Lupien, Mathieu ^b,c   Silver, Pamela A ^a   Brown, Myles ^b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CARM1 ENZYME; ESTROGEN RECEPTOR ALPHA; HISTONE H3; PROTEIN ARGININE METHYLTRANSFERASE; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; COACTIVATOR ASSOCIATED ARGININE METHYLTRANSFERASE 1; COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1; E2F1 PROTEIN, HUMAN; ESTRADIOL; ESTROGEN;

ARTICLE; BREAST CANCER; CANCER GROWTH; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; BREAST TUMOR; DRUG ANTAGONISM; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; E2F1 TRANSCRIPTION FACTOR; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; PROMOTER REGIONS (GENETICS); PROTEIN-ARGININE N-METHYLTRANSFERASE;

EID: 39149092383     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-1983     Document Type: Article

References (35)

1. Doisneau-Sixou SF, Sergio CM, Carroll JS, Hui R, Musgrove EA, Sutherland RL. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Endocr Relat Cancer 2003;10:179-86.
2. Klinge CM. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 2001;29:2905-19.
3. Altucci L, Addeo R, Cicatiello L, et al. 17β-Estradiol induces cyclin D1 gene transcription, p36D1-34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene 1996;12:2315-24.
4. Eeckhoute J, Carroll JS, Geistlinger TR, Torres-Arzayus MI, Brown M. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes Dev 2006;20:2513-26.
5. Musgrove EA, Hamilton JA, Lee CS, Sweeney KJ, Watts CK, Sutherland RL. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol 1993;13:3577-87.
6. Wang W, Dong L, Saville B, Safe S. Transcriptional activation of E2F1 gene expression by 17β-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions. Mol Endocrinol 1999;13:1373-87.
7. Dimova DK, Dyson NJ. The E2Ftr anscriptional network: old acquaintances with new faces. Oncogene 2005;24:2810-26.
8. Wickerham L. Tamoxifen - an update on current data and where it can now be used. Breast Cancer Res Treat 2002;75 Suppl 1:S7-12; discussion S33-5.
9. Carroll JS, Liu XS, Brodsky AS, et al. Chromosome-wide mapping of estrogen receptor binding reveals longrange regulation requiring the forkhead protein FoxA1. Cell 2005;122:33-43.
10. Carroll JS, Meyer CA, Song J, et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet 2006;38:1289-97.
11. Green KA, Carroll JS. Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state. Nat Rev 2007;7:713-22.
12. Louie MC, Zou JX, Rabinovich A, Chen HW. ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol Cell Biol 2004;24:5157-71.
13. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000;103:843-52.
14. Teyssier C, Chen D, Stallcup MR. Requirement for multiple domains of the protein arginine methyltransferase CARM1 in its transcriptional coactivator function. J Biol Chem 2002;277:46066-72.
15. Metivier R, Penot G, Hubner MR, et al. Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003;115:751-63.
16. Shao W, Keeton EK, McDonnell DP, Brown M. Coactivator AIB1 links estrogen receptor transcriptional activity and stability. Proc Natl Acad Sci U S A 2004;101:11599-604.
17. Keeton EK, Brown M. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-α and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT. Mol Endocrinol 2005;19:1543-54.
18. Stallcup MR. Role of protein methylation in chromatin remodeling and transcriptional regulation. Oncogene 2001;20:3014-20.
19. Katzenellenbogen BS, Montano MM, Ekena K, Herman ME, McInerney EM, William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer. Breast Cancer Res Treat 1997;44:23-38.
20. Yan J, Tsai SY, Tsai MJ. SRC-3/AIB1: transcriptional coactivator in oncogenesis. Acta Pharmacol Sin 2006;27:387-94.
21. Majumder S, Liu Y, Ford OH III, Mohler JL, Whang YE. Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability. Prostate 2006;66:1292-301.
22. El Messaoudi S, Fabbrizio E, Rodriguez C, et al. Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the cyclin E1 gene. Proc Natl Acad Sci U S A 2006;103:13351-6.
23. Covic M, Hassa PO, Saccani S, et al. Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-κB-dependent gene expression. EMBO J 2005;24:85-96.
24. Ma H, Baumann CT, Li H, et al. Hormone-dependent, CARM1-directed, arginine-specific methylation of histone H3 on a steroid-regulated promoter. Curr Biol 2001;11:1981-5.
25. Stender JD, Frasor J, Komm B, Chang KC, Kraus WL, Katzenellenbogen BS. Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation. Mol Endocrinol 2007;21:2112-23.
26. Neuman E, Flemington EK, Sellers WR, Kaelin WG, Jr. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2FDNA-binding sites within its promoter. Mol Cell Biol 1994;14:6607-15.
27. Johnson DG, Ohtani K, Nevins JR. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev 1994;8:1514-25.
28. Stallcup MR, Kim JH, Teyssier C, Lee YH, Ma H, Chen D. The roles of protein-protein interactions and protein methylation in transcriptional activation by nuclear receptors and their coactivators. J Steroid Biochem Mol Biol 2003;85:139-45.
29. Katzenellenbogen BS, Montano MM, Ediger TR, et al. Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res 2000;55:163-93; discussion 94-5.
30. Daujat S, Bauer UM, Shah V, Turner B, Berger S, Kouzarides T. Crosstalk between CARM1 methylation and CBP acetylation on histone H3. Curr Biol 2002;12:2090-7.
31. Bedford MT, Richard S. Arginine methylation an emerging regulator of protein function. Mol Cell 2005;18:263-72.
32. Fabbrizio E, El Messaoudi S, Polanowska J, et al. Negative regulation of transcription by the type II arginine methyltransferase PRMT5. EMBO Rep 2002;3:641-5.
33. Pal S, Vishwanath SN, Erdjument-Bromage H, Tempst P, Sif S. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol 2004;24:9630-45.
34. Hong H, Kao C, Jeng MH, et al. Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status. Cancer 2004;101:83-9.
35. Planas-Silva MD, Shang Y, Donaher JL, Brown M, Weinberg RA. AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Cancer Res 2001;61:3858-62.